Background Atrial fibrillation (AF) is linked to significant morbidity and mortality, with ischaemic stroke being a leading ...

The proprotein convertase subtilisin–kexin type 9 (PCSK9) inhibitor evolocumab reduces the risk of major adverse cardiovascular events (MACE) among patients with a previous myocardial infarction, ...

Neurologists emphasize that skipping routine medical checkups may be one of the most dangerous yet overlooked habits linked ...

According to reports 1, stroke was the second leading cause of death globally in 2019, which will increase the economic burden in various countries, especially in low-income countries; ischemic stroke ...

Researchers at the Medical University of Vienna and ETH Zurich have developed a rehabilitation platform for people suffering ...

To examine heterogeneity in the impact of increased early rehabilitation intensity and to identify which ischemic stroke patients benefit most. We analysed 39,140 propensity score-matched ischemic ...

Patients with noncardioembolic ischemic stroke or transient ischemic attack (TIA) are at risk for recurrent stroke. Low factor XI levels are associated with a reduced risk of ischemic stroke.

By tamping down metabolism, a new experimental treatment that induces a hypothermia-like state may slow stroke-associated ...

Landmark, lifesaving telerobotic mechanical thrombectomy to expand access to care for stroke, a leading cause of death and disability worldwide HOUSTON & PANAMA CITY, Panama--(BUSINESS WIRE)--XCath, a ...

A stroke happens when blood flow to part of the brain is blocked or when a blood vessel in the brain bursts. Without enough ...